Nature Communications (Jul 2024)

PDX1+ cell budding morphogenesis in a stem cell-derived islet spheroid system

  • Jia Zhao,
  • Shenghui Liang,
  • Haoning Howard Cen,
  • Yanjun Li,
  • Robert K. Baker,
  • Balwinder Ruprai,
  • Guang Gao,
  • Chloe Zhang,
  • Huixia Ren,
  • Chao Tang,
  • Liangyi Chen,
  • Yanmei Liu,
  • Francis C. Lynn,
  • James D. Johnson,
  • Timothy J. Kieffer

DOI
https://doi.org/10.1038/s41467-024-50109-2
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Remarkable advances in protocol development have been achieved to manufacture insulin-secreting islets from human pluripotent stem cells (hPSCs). Distinct from current approaches, we devised a tunable strategy to generate islet spheroids enriched for major islet cell types by incorporating PDX1+ cell budding morphogenesis into staged differentiation. In this process that appears to mimic normal islet morphogenesis, the differentiating islet spheroids organize with endocrine cells that are intermingled or arranged in a core-mantle architecture, accompanied with functional heterogeneity. Through in vitro modelling of human pancreas development, we illustrate the importance of PDX1 and the requirement for EphB3/4 signaling in eliciting cell budding morphogenesis. Using this new approach, we model Mitchell-Riley syndrome with RFX6 knockout hPSCs illustrating unexpected morphogenesis defects in the differentiation towards islet cells. The tunable differentiation system and stem cell-derived islet models described in this work may facilitate addressing fundamental questions in islet biology and probing human pancreas diseases.